Plaid, a fintech unicorn known for its APIs that connect consumer bank accounts to financial applications, announced today that it is buying Cognito. The ...

In addition, Cognito said in Tuesday’s announcement that it plans to use the biomarker analyses to look for indicators of Alzheimer’s progression and to spot new disease areas that may also ...

An experimental device developed by Cognito Therapeutics seeks to slow cognitive decline in Alzheimer’s patients using light and sound.

Cognito Therapeutics just raised $73 million to test its headset in 500 patients with Alzheimer's disease.

Ian Cognito, a British comic, fell ill during his stand-up set at the Atic bar in the English town of Bicester, 14 miles north of Oxford, according to CNN.

Cognito Therapeutics has spent the better part of the last decade developing neuromodulation technology that it claims could stop and even reverse the progression of Alzheimer’s and other ...

About Cognito Therapeutics Cognito Therapeutics is a clinical-stage neurotechnology company developing disease-modifying therapeutic approaches to treat neurodegenerative disorders.

Just as a new wave of approved drugs for Alzheimer’s reaches patients, Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment.

Veteran British comedian Ian Cognito died on stage Thursday evening during a stand-up performance.